Shortcuts

open access

Vol 10, No 2 (2008)
Prace oryginalne
Published online: 2008-11-14
Get Citation

The influence of diabetes mellitus on stroke

Marek Zalisz
Udar Mózgu. Problemy Interdyscyplinarne 2008;10(2):61-69.

open access

Vol 10, No 2 (2008)
Prace oryginalne
Published online: 2008-11-14

Abstract

Introduction. The purpose of study is to find out if DM its degree equalization connected with level of HbA1c. Influences theclinical symptoms and research outcomes in stroke, estimation of the influence DM on the course of stroke and its implications during hospitalization and the year after stroke.
Material and methods. It’s prospective, no interventional, with one year follow-up study on patients groups after stroke in Neurology Department since 01.2005 to 07.2007. Some parameters were used to describe the clinical symptoms, course of stroke and consequences of stroke in one year follow-up in groups: I - with DM, Ia - DM non-equalized, Ib - DM equalized, II - without DM. Each patient is classified according to HbA1c score.
Results. 188 patients hospitalized due to stroke took part in the study in Neurology Department in Dzialdowo. Diabetes patients (I) consist 70 people (37%), amongst them 51 (%) with DM non-equalized (Ia) and 19 (10,1 %) DM equalized (Ib). Non-diabetes patients constitute a group of 118 people (62,8%). We showed the differences between analyzed groups.
Conclusions. Diabetes mellitus influences to clinical image of stroke. The patients with stroke and DM have lacunar infarct more frequently. The degree of DM equalization does not influence stroke clinical symptoms and stroke course. They are in better functional and neurological condition on admission, but during hospitalization and on discharge they achieve similar conditions. Complications during hospitalization occur more often in DM non-equalized group. DM influences negatively on the functional conditions in one year follow-up, particularly on non-equalized group.

Abstract

Introduction. The purpose of study is to find out if DM its degree equalization connected with level of HbA1c. Influences theclinical symptoms and research outcomes in stroke, estimation of the influence DM on the course of stroke and its implications during hospitalization and the year after stroke.
Material and methods. It’s prospective, no interventional, with one year follow-up study on patients groups after stroke in Neurology Department since 01.2005 to 07.2007. Some parameters were used to describe the clinical symptoms, course of stroke and consequences of stroke in one year follow-up in groups: I - with DM, Ia - DM non-equalized, Ib - DM equalized, II - without DM. Each patient is classified according to HbA1c score.
Results. 188 patients hospitalized due to stroke took part in the study in Neurology Department in Dzialdowo. Diabetes patients (I) consist 70 people (37%), amongst them 51 (%) with DM non-equalized (Ia) and 19 (10,1 %) DM equalized (Ib). Non-diabetes patients constitute a group of 118 people (62,8%). We showed the differences between analyzed groups.
Conclusions. Diabetes mellitus influences to clinical image of stroke. The patients with stroke and DM have lacunar infarct more frequently. The degree of DM equalization does not influence stroke clinical symptoms and stroke course. They are in better functional and neurological condition on admission, but during hospitalization and on discharge they achieve similar conditions. Complications during hospitalization occur more often in DM non-equalized group. DM influences negatively on the functional conditions in one year follow-up, particularly on non-equalized group.
Get Citation

Keywords

stroke; diabetes mellitus; glycosylated hemoglobin

About this article
Title

The influence of diabetes mellitus on stroke

Journal

Interdisciplinary Problems of Stroke

Issue

Vol 10, No 2 (2008)

Pages

61-69

Published online

2008-11-14

Bibliographic record

Udar Mózgu. Problemy Interdyscyplinarne 2008;10(2):61-69.

Keywords

stroke
diabetes mellitus
glycosylated hemoglobin

Authors

Marek Zalisz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl